SEC Form 4 · accession 0001628280-18-013558
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott R Tobin
Director
Period of report
Nov 1, 2018
Accepted (ET)
Nov 5, 2018 · 11:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $12.73 | Nov 1, 2018 | A | 10,000 | A | — | Nov 1, 2023 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018, February 1, 2019, May 1, 2019 and August 1, 2019, respectively.